( en | de | ru )

 

Disambiguation of "Findlow, Jamie"

Author of the publication

copydeleteadd this publication to your clipboard
Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles

, , , , , , , , , , , , and . Clin. Vaccine Immunol., 16 (8): 1113--1120 (August 2009)
DOI: 10.1128/CVI.00118-09

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jamie O'Sullivan

Molecular cooling and emissions in large scale simulations of protostellar jets. Uni Heidelberg, (2009)

Kyle Jamieson

Jamie Furness

Jamie Garside

Jamie Hillman

 

Other publications of authors with the same name

Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era, , , , , , and . Clinical and Vaccine Immunology: CVI, 15 (11): 1694--8 (November 2008)PMID: 18827191.Prevention of meningococcal serogroup C disease by NeisVac-C, and . Expert Review of Vaccines, 8 (3): 265--279 (March 2009)PMID: 19249967.Immunogenicity of 2 Investigational Serogroup B Meningococcal Vaccines in the First Year of Life, , , , , , , , , and 2 other author(s). The Pediatric Infectious Disease Journal, (2010)Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine, , , , , , , , , and . Clin. Vaccine Immunol., 17 (1): 154--159 (January 2010)Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy, , , , , , , , , and 3 other author(s). Clinical Infectious Diseases, 51 (10): 1127--1137 (November 2010)A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H-Binding Proteins and Implications for Vaccine Coverage in Different Age Groups, , , , , , , , , and 12 other author(s). The Pediatric infectious disease journal, 32 (10): 1096--1101 (October 2013)PMID: 23694830.Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom, , , , , , , , , and . Clin. Vaccine Immunol., 16 (2): 194--199 (February 2009)Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines, , , , , , , , , and 24 other author(s). Clinical and vaccine immunology: CVI, 19 (10): 1609--1617 (October 2012)PMID: 22875603.Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, , , , , , , , , and 26 other author(s). The Lancet infectious diseases, 13 (5): 416--425 (May 2013)PMID: 23414709.Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine, , , , , and . Journal of Occupational Medicine and Toxicology, 8 (1): 4 (March 2013)